Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaya Leaf Extract for Thrombocytopenia in Pediatric Dengue
NCT07172100Phase 2Enrolling by invitation
- Sponsor
- Ziauddin Hospital
- Start
- Oct 2025
- Primary completion
- Nov 2025
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carica papaya leaf extract in dengue fever (2 arms), sponsored by Ziauddin Hospital. Primary endpoint: Change in Platelet Count from Day 1 to Day 3. Started Oct 2025; status: enrolling by invitation.
02
Drugs
carica papaya leaf extract
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT07172100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172100.